Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
HhdcASX6Rc8bdWC9